Study to Determine the Effect of Food on the Blood Levels of AZD9291 Following Oral Dosing of a Tablet Formulation in Patients With Non-Small Cell Lung Cancer
An Open-label, Randomised, Phase I, Study to Determine the Effect of Food on the Pharmacokinetics of Single Oral Doses of AZD9291 in Patients With EGFRm Positive NSCLC Whose Disease Has Progressed on an EGFR TKI
Sponsor: AstraZeneca
A PHASE1 clinical study on Advanced (Inoperable) Non Small Cell Lung Cancer and Advanced Non Small Cell Lung Cancer, this trial is completed. The trial is conducted by AstraZeneca and has accumulated 30 data snapshots since 2014. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
30 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE1
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Feb 2024 — Jul 2024 [monthly]
Completed PHASE1
-
Mar 2023 — Feb 2024 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
▶ Show 25 earlier versions
-
Feb 2023 — Mar 2023 [monthly]
Active Not Recruiting PHASE1
-
Sep 2022 — Feb 2023 [monthly]
Active Not Recruiting PHASE1
-
Jul 2022 — Sep 2022 [monthly]
Active Not Recruiting PHASE1
-
Mar 2022 — Jul 2022 [monthly]
Active Not Recruiting PHASE1
-
Jan 2022 — Mar 2022 [monthly]
Active Not Recruiting PHASE1
-
Dec 2021 — Jan 2022 [monthly]
Active Not Recruiting PHASE1
-
Oct 2021 — Dec 2021 [monthly]
Active Not Recruiting PHASE1
-
Sep 2021 — Oct 2021 [monthly]
Active Not Recruiting PHASE1
-
May 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE1
-
Jan 2021 — May 2021 [monthly]
Active Not Recruiting PHASE1
-
Oct 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1
-
Jul 2020 — Oct 2020 [monthly]
Active Not Recruiting PHASE1
-
Apr 2020 — Jul 2020 [monthly]
Active Not Recruiting PHASE1
-
Jan 2020 — Apr 2020 [monthly]
Active Not Recruiting PHASE1
-
Dec 2019 — Jan 2020 [monthly]
Active Not Recruiting PHASE1
-
Aug 2019 — Dec 2019 [monthly]
Active Not Recruiting PHASE1
-
Jun 2019 — Aug 2019 [monthly]
Active Not Recruiting PHASE1
-
Feb 2019 — Jun 2019 [monthly]
Active Not Recruiting PHASE1
-
Dec 2018 — Feb 2019 [monthly]
Active Not Recruiting PHASE1
-
Jul 2018 — Dec 2018 [monthly]
Active Not Recruiting PHASE1
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting PHASE1
-
Aug 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE1
-
Jul 2017 — Aug 2017 [monthly]
Active Not Recruiting PHASE1
-
Feb 2017 — Jul 2017 [monthly]
Active Not Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE1
First recorded
Nov 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AstraZeneca
For direct contact, visit the study record on ClinicalTrials.gov .